Personalized high-definition transcranial direct current stimulation is linked to improved outcomes in moderate-to-severe ...
A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some side effects common to other antidepressants.
MedPage Today on MSN
Novel Drug Fails to Outperform Common Treatment in Depression and Insomnia
An investigational drug did not significantly improve outcomes versus quetiapine extended release (Seroquel XR) as an ...
A new study shows that a personalized, precise form of brain stimulation, HD-tDCS, can rapidly ease depression symptoms – and ...
Atai Life Sciences (NASDAQ:ATAI) and Beckley Psytech Limited, a private clinical-stage biopharmaceutical company, released data from a proof-of-concept study investigating a two-dose induction regimen ...
Electroacupuncture added to standard care improved sleep quality in people with depression-related insomnia, a randomized clinical trial showed. At 8 weeks, a -6.2 point change (95% CI -6.9 to -5.6) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback